<DOC>
	<DOCNO>NCT00668343</DOCNO>
	<brief_summary>Patient relapse remit multiple sclerosis take avonex include double blind randomize control trial . Simvastatin compare placebo . end point edss , total attack , new enhance lesion newt2 lesion mri evaluate end point .</brief_summary>
	<brief_title>Simvastatin Relapsing Remitting Multiple Sclerosis ( RRMS ) Patients Using Avonex Compared Placebo</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>1. edss &lt; 5 2 . &gt; =1 attack last year 1 . &gt; 2 attack study 2. drug complication</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>edss attack</keyword>
</DOC>